BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Salix Pharmaceuticals, Ltd. Reports 2Q2013 Results

  August 9, 2013

   · 

  1 min read
• BioMidwest

  Over 50% of U.S. News & World Report’s “Best Heart Hospitals” are Certified to Implant the SynCardia Systems, Inc. Total Artificial Heart

  August 9, 2013

   · 

  3 min read
• Pharm Country

  CureMark Awarded New Patent for Treatment of Drug and Alcohol Addiction

  August 9, 2013

   · 

  3 min read
• Genetown

  Boston Scientific Corporation Prices $1.05 Billion of Senior Notes

  August 9, 2013

   · 

  4 min read
• Business

  Select Medical Announces Results for Second Quarter Ended June 30, 2013 and Quarterly Cash Dividend

  August 9, 2013

   · 

  1 min read
• Genetown

  Company Profile for Alere Analytics

  August 9, 2013

   · 

  1 min read
• FDA

  Celgene International Sárl’s Oral Anti-Cancer Therapy Pomalidomide Gets European Commission (EC) Approval

  August 9, 2013

   · 

  13 min read
• AxoGen, Inc. Announces Pricing of $18 Million Underwritten Offering and Uplisting to NASDAQ

  August 9, 2013

   · 

  4 min read
• Business

  Boston Therapeutics, Inc. Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013

  August 9, 2013

   · 

  5 min read
• Drug Development

  Bio-Path Holdings, Inc.’s Liposomal Delivery Technology Achieves Major Milestone in Development of Antisense Therapeutics

  August 9, 2013

   · 

  1 min read